Assessing quality of life and function in patients after pelvic tumor surgery
Quality of Life and Function of Patients After Hemipelvectomy
This study is trying to see how surgery for pelvic tumors affects patients' daily life and physical abilities over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05134142 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on evaluating the functional outcomes of patients who have undergone hemipelvectomy, either internal with or without reconstruction or external, due to pelvic tumors. The study aims to assess various factors influencing these outcomes, including sexual and urinary function, through physical performance assessments and quality of life questionnaires. Patients will be evaluated pre-surgery, at 6 weeks post-surgery, and then every 3 months for up to 12 months, with annual assessments for up to 10 years. The goal is to gather comprehensive data that may inform future surgical approaches and improve patient quality of life.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have undergone or are scheduled to undergo a hemipelvectomy due to pelvic tumors.
Not a fit: Patients who have not undergone hemipelvectomy or those with other unrelated conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of long-term outcomes for patients undergoing hemipelvectomy, enhancing their quality of life.
How similar studies have performed: While this study focuses on a specific surgical procedure, similar studies assessing functional outcomes post-surgery have shown promising results, indicating the potential for valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients within the institution who have undergone or will undergo a hemipelvectomy Exclusion Criteria: \- None
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Valerae O Lewis — M.D. Anderson Cancer Center
- Study coordinator: Valerae O Lewis
- Email: volewis@mdanderson.org
- Phone: 713-792-5073
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.